Biospyder Technologies Inc Profile last edited on: 9/26/2022
CAGE: 6THH7
UEI: KLCPP1J49GC5
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 49
County: San Diego
Congr. District: 49
County: San Diego
Public Profile
BioSpyder is a molecular profiling company engaged in the development and commercialization of TempO-Seq technology, a novel expression profiling assay platform for measuring DNA, RNA and Proteins. TempO-seq is a robust, inexpensive and versatile assay platform well suited for rapid modification for many molecular profiling applications involving DNA, RNA and Proteins. The firm offer whole transcriptome products for human, Rat and mouse but can quickly develop fixed or custom panels for any signature, species or sample type.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
20-24Revenue Range
2M-2.5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
15-19Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2024 | 2 | NIH | $3,075,516 | |
| Project Title: Whole Blood Filter Paper Assay for Alzheimers Disease | ||||
| 2023 | 2 | NIH | $2,902,187 | |
| Project Title: TempO-LINC high throughput, high sensitivity single cell gene expression profiling assay | ||||
| 2021 | 1 | NIH | $252,121 | |
| Project Title: TempO-Seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk | ||||
| 2021 | 2 | NIH | $1,413,116 | |
| Project Title: TempO-Seq Profiling of RNA Epitranscriptomic Modifications | ||||
| 2020 | 1 | NIH | $224,980 | |
| Project Title: Functional Read-Out Enabling High Compound Throughput Toxicokinetic Assays | ||||
Key People / Management
Joel Mccomb -- Founder and CE
Milos Babic
Susanne L Cassidy
Bruce E Seligmann -- Founder, Board Member and Chief Science Officer
Bruce E Seligmann -- Chief Scientific Officer and Co-Founder
Christine Yeakley -- Web Developer (volunteer)
Joanne M Yeakley -- VP, R&D and Co-FounderVP, R&D and Co-Founder
Milos Babic
Susanne L Cassidy
Bruce E Seligmann -- Founder, Board Member and Chief Science Officer
Bruce E Seligmann -- Chief Scientific Officer and Co-Founder
Christine Yeakley -- Web Developer (volunteer)
Joanne M Yeakley -- VP, R&D and Co-FounderVP, R&D and Co-Founder
Company News
There are no news available.
